Dual-view jointly learning improves personalized drug synergy prediction
Preprint in bioRxiv (March 2024)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
PIK3CA mutation as an acquired resistance driver to EGFR-TKIs in non-small cell lung cancer: Clinical challenges and opportunities
Article in Pharmacological Research (March 2024)
Attenuation of PI3K-Akt-mTOR Pathway to Reduce Cancer Stemness on Chemoresistant Lung Cancer Cells by Shikonin and Synergy with BEZ235 Inhibitor
Article in International Journal of Molecular Sciences (January 2024)